What is Nexperia?
Founded in 2017 and headquartered in Nijmegen, Netherlands, Nexperia has rapidly established itself as a powerhouse in the discrete semiconductor market. The company specializes in the high-volume production of bipolar transistors, diodes, ESD protection devices, TVS diodes, MOSFETs, and logic integrated circuits. By maintaining a robust manufacturing footprint, Nexperia serves as a foundational pillar for modern electronics, ensuring the reliability and efficiency of complex systems across diverse global industries. Its market position is defined by a commitment to high-performance standards and the ability to scale production to meet the rigorous demands of enterprise-level clients.
How much funding has Nexperia raised?
Nexperia has raised a total of $1.5B across 1 funding round:
Debt
$1.5B
Debt (2019): $1.5B with participation from HSBC Global Coordinators, Bank of America Merrill Lynch, and ABN AMRO
Key Investors in Nexperia
HSBC Global Coordinators
A leading international banking and financial services organization providing comprehensive corporate financing solutions.
Bank of America Merrill Lynch
A global financial institution offering a wide range of investment banking and capital market services to large-scale enterprises.
ABN AMRO
Established in 1991 and headquartered in North Holland, Netherlands, ABN AMRO is a company that provides banking services for retail, private, and corporate banking sectors.
What's next for Nexperia?
The infusion of capital from this debt financing round provides Nexperia with the necessary liquidity to accelerate its strategic growth initiatives. Moving forward, the company is expected to focus on expanding its product portfolio and enhancing its manufacturing capacity to address the increasing global demand for advanced power management solutions. By leveraging this financial backing, Nexperia is well-positioned to navigate the competitive semiconductor landscape, potentially pursuing further technological innovation and operational efficiencies that will sustain its long-term market leadership.
See full Nexperia company page
